Ergot physiology. the production of ergot alkaloids in saprophytic culture by a homokaryotic strain of ergot
Robbers, J.E.; Jones, L.G.; Krupinski, V.M.
Lloydia 37(1): 108-111
1974
ISSN/ISBN: 0024-5461 PMID: 4133589 Document Number: 81710
Document emailed within 1 workday
Related Documents
Venn, R.D. 1976: Electroencephalogram and ergot alkaloids Postgraduate Medical Journal 52suppl. 1: 55-56Walter, U. 1979: Risks of ergot alkaloids in obstetrics Medizinische Monatsschrift für Pharmazeuten 2(3): 76-80
Sterzl, J.; Rehácek, Z.; Cudlín, J. 1987: Regulation of the immune response by ergot alkaloids Czechoslovak Medicine 10(2): 90-98
Gorini, A.; Arnaboldi, R.; Vercesi, L.; Dossena, M. 1988: Influence of some ergot alkaloids on the cerebral reduced glutathione Il Farmaco; Edizione Scientifica 43(11): 887-890
Bernardi, L. 1979: From ergot alkaloids to nicergoline/Chemical points of view Arzneimittel-Forschung 29(8a): 1204-1206
Schran, H.F.; Schwarz, H.J.; Talbot, K.C.; Loeffler, L.J. 1979: Specific radioimmunoassay of ergot peptide alkaloids in plasma Clinical Chemistry 25(11): 1928-1933
Mercier, C. 1982: Peptide alkaloids of spurred rye and their semisynthetic derivatives. III. Ergot in therapeutics Journal de Pharmacie de Belgique 37(4): 289-298
Eich, E.; Pertz, H. 1994: Ergot alkaloids as lead structures for differential receptor systems Die Pharmazie 49(12): 867-877
Floss, H.G.; Basmadjian, G.P.; Tcheng, M.; Gröger, D.; Erge, D. 1971: Biosynthesis of peptide-type ergot alkaloids. Ergocornine and ergocryptine Lloydia 34(4): 446-448
Schmitt, H.; Fenard, S. 1970: Effects of ergot alkaloids on the vasomotor centers and their inhibition by clonidine Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 164(5): 1006-1009
Vaupel, P.; Hutten, H. 1980: Acute changes in intracerebral vascular resistance after application of dihydrogenated ergot alkaloids Arzneimittel-Forschung 30(4): 598-602
Gröger, D.; Syring, U.; Johne, S. 1975: Syntheses of radioactive cyclols as potential precursors of the peptide moiety of ergot alkaloids Die Pharmazie 30(7): 440-443
Loew, D.M.; Depoortere, H.; Buerki, H.R. 1976: Effects of dihydrogenated ergot alkaloids on the sleep-wakefulness cycle and on brain biogenic amines in the rat Arzneimittel-Forschung 26(6): 1080-1083
Kozlovskiĭ, A.G.; Zhelifonova, V.P.; Antipova, T.V.; Zelenkova, N.F. 2011: Physiological and biochemical characteristics of fungi of the genus Penicillium as producers of ergot alkaloids and quinocitrinins Prikladnaia Biokhimiia i Mikrobiologiia 47(4): 469-473
Sarsúnová, M.; Semonský, M.; Cerný, A. 1970: Ergot alkaloids. XXXVI. Separation of diastereomeric (+)-1-hydroxy-2-butylamides of D- and L-lysergic and D- and L-isolysergic acids by thin-layer chromatography Journal of Chromatography 50(3): 442-446
Mann, D.F.; Floss, H.G. 1977: Purification and properties of anthranilate synthetase from the ergot fungus, Claviceps spec., strain SD 58 Lloydia 40(2): 136-145
Miragoli, G.; Ferrini, R. 1974: Effect of the combination of raubasine and hydrogenated ergot alkaloids on the isolated and perfused rat caudal artery and rabbit internal carotid artery Bollettino della Societa Italiana di Biologia Sperimentale 50(19): 1622-1628
Petkov, V.; Georgiev, V.; Roussinov, K.; Grigorov, I.; Slokoska, L.; Angelova, M.; Lazarova, M.; Getova, D.; Todorov, S.; Radomirov, R. 1984: On the pharmacology of the ergot alkaloid elymoclavine Biomedica Biochimica Acta 43(11): 1305-1316
Walter, U.; Stoll, W. 1978: Ergot-alcaloids and stimulation of labour Schweizerische Rundschau für Medizin Praxis 67(12): 435-439
Von Werder, K. 1983: Dopaminergic ergot combinations. a new therapeutic principle Münchener Medizinische Wochenschrift 125(23): 489-491